Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula ▼ |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EN05 |
|
44261832 | 2434.27174 | C110H195N5O53 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BG05 |
|
44260864 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BJ05 |
|
44260888 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CC05 |
|
44261408 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CT05 |
|
44261536 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE05 |
|
44261768 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF05 |
|
44261776 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EG05 |
|
44261784 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EI05 |
|
44261800 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BK04 |
|
44260895 | 2447.266989 | C110H194N6O53 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EH04 |
|
44261791 | 2447.266989 | C110H194N6O53 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EA03 |
|
44261734 | 2483.240501 | C110H194N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED03 |
|
44261758 | 2483.240501 | C110H194N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EB03 |
|
44261742 | 2467.245586 | C110H194N4O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EC03 |
|
44261750 | 2467.245586 | C110H194N4O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BB03 |
|
44261190 | 2451.250671 | C110H194N4O55 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CO08 |
|
44261499 | 2419.260841 | C110H194N4O53 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AZ08 |
|
44260819 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BB08 |
|
44260835 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AR08 |
|
44261115 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX08 |
|
44261163 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BC08 |
|
44261203 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CH08 |
|
44261451 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BQ02 |
|
44261309 | 2512.230665 | C110H193N5O58 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BX02 |
|
44261365 | 2512.230665 | C110H193N5O58 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024